Mirae Asset Global Investments Co., Ltd. Repligen Corp Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Repligen Corp stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 18,629 shares of RGEN stock, worth $2.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
18,629
Previous 12,716
46.5%
Holding current value
$2.7 Million
Previous $1.89 Million
41.7%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding RGEN
# of Institutions
482Shares Held
56.3MCall Options Held
251KPut Options Held
458K-
Black Rock Inc. New York, NY7.57MShares$1.1 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.14MShares$1.03 Billion0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$739 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$245 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.54MShares$224 Million1.48% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.04B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....